Suncoast Equity Management’s AbbVie ABBV Stock Holding History

Suncoast Equity Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-7,716	Closed	-$1.25M	–	57
2022 Q1	$1.25M	Buy	7,716 +486	+7%	+$70.6K	0.19%	27
2021 Q4	$979K	Buy	7,230 +420	+6%	+$49.6K	0.12%	28
2021 Q3	$735K	Sell	6,810 -640	-9%	-$73.1K	0.1%	29
2021 Q2	$839K	Buy	7,450 +1,615	+28%	+$182K	0.11%	27
2021 Q1	$631K	Buy	5,835 +105	+2%	+$11.2K	0.09%	29
2020 Q4	$614K	Buy	5,730 +445	+8%	+$42.8K	0.1%	29
2020 Q3	$463K	Buy	5,285 +200	+4%	+$18.8K	0.08%	28
2020 Q2	$499K	Buy	5,085 +800	+19%	+$70.4K	0.09%	26
2020 Q1	$326K	Buy	+4,285	New	+$365K	0.08%	30
2014 Q2	–	Sell	-53,745	Closed	-$2.76M	–	21
2014 Q1	$2.76M	Buy	53,745 +805	+2%	+$40.7K	2.79%	17
2013 Q4	$2.8M	Buy	52,940 +2,135	+4%	+$105K	2.84%	17
2013 Q3	$2.27M	Sell	50,805 -553	-1%	-$24.5K	2.66%	16
2013 Q2	$2.12M	Buy	+51,358	New	+$2.25M	2.71%	16

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Suncoast Equity Management's ABBV Position: Q2 2022 in Review

Suncoast Equity Management sold out of AbbVie (ABBV) in Q2 2022, closing a stake of 7,716 shares — an estimated $1.25M sold.

Suncoast Equity Management first reported a position in ABBV in Q2 2013 and held it in 13 quarters. The position peaked at $2.8M in Q4 2013. 3,005 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

Suncoast Equity Management reported no remaining AbbVie position as of Q2 2022 after selling out during the quarter.
Suncoast Equity Management sold 7,716 AbbVie shares in Q2 2022, an estimated $1.25M.
Suncoast Equity Management first reported a position in AbbVie in Q2 2013 and held it in 13 quarters.
Suncoast Equity Management's AbbVie position peaked at $2.8M in Q4 2013.
3,005 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on Suncoast Equity Management's 13F filing for Q2 2022, filed 18 Jul 2022.